Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_4526
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 4526
Character Range: 2139049–2139968

4526                                      SILVER BOROSILICATE                                                                      E         Only for use in topical medicines for dermal application and not to be included in medicines intended for use in the eye.
                                                                                                                                             The concentration in the medicine should be no more than 0.6%.
                                                                                                                                             Silver is a mandatory component of Silver borosilicate when the route of administration is topical.
                                                                                                                                             The concentration of silver in the medicine must be no more than 1%.